Ernexa Therapeutics Inc (ERNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,078 | 3,785 | 2,635 | 3,378 | 4,464 |
| Receivables | 1,279 | 787 | 1,033 | 714 | 627 |
| Other current assets | 3,600 | 3,798 | 3,991 | 4,866 | 4,654 |
| TOTAL | $8,529 | $9,213 | $8,728 | $9,638 | $10,745 |
| Non-Current Assets | |||||
| PPE Net | 3,645 | 3,922 | 3,753 | 3,678 | 3,485 |
| Intangibles | 976 | 955 | 978 | 1,004 | 1,012 |
| Other Non-Current Assets | 2,394 | 2,266 | 2,242 | 2,250 | 2,321 |
| TOTAL | $7,015 | $7,143 | $6,973 | $6,932 | $6,818 |
| Total Assets | $15,544 | $16,356 | $15,701 | $16,570 | $17,563 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,104 | 2,210 | 1,942 | 5,059 | 5,162 |
| Accounts payable and accrued liabilities | 341 | 427 | 521 | 390 | 579 |
| Accrued Expenses | 1,152 | 1,167 | 909 | 1,064 | 1,128 |
| Other current liabilities | 96 | 98 | 146 | 192 | 106 |
| TOTAL | $5,542 | $7,137 | $7,339 | $10,747 | $10,937 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,977 | 2,510 | 2,952 | 8 | 92 |
| Deferred Revenues | 2,520 | 2,932 | 3,533 | 3,746 | 3,714 |
| Other Non-Current Liabilities | 50 | 48 | 50 | 52 | 18 |
| TOTAL | $3,106 | $2,683 | $3,166 | $287 | $568 |
| Total Liabilities | $8,648 | $9,820 | $10,505 | $11,034 | $11,505 |
| Shareholders' Equity | |||||
| Common Shares | 14 | 14 | 13 | 13 | 13 |
| Retained earnings | -129,438 | -129,660 | -129,528 | -129,119 | -128,472 |
| Other shareholders' equity | -162 | -201 | -158 | -110 | -96 |
| TOTAL | $6,896 | $6,536 | $5,196 | $5,536 | $6,058 |
| Total Liabilities And Equity | $15,544 | $16,356 | $15,701 | $16,570 | $17,563 |